Cancer Therapy News and Research

RSS

VA announces new ROPA program to improve radiation therapy cancer care for Veterans

The Department of Veterans Affairs today announced a new Radiation Oncology Practice Assessment (ROPA) program to leverage recent advances in information technology to improve radiation therapy cancer care for our nation's Veterans.

19 Nov 2015

Med Data Quest collaborates with WuXi AppTec to tackle oncology informatics challenges

Med Data Quest, a pioneering medical informatics total solution provider, today celebrates its successful collaboration with the Oncology Business Unit of the CRO giant WuXi AppTec, delivering the world's first mobile App OncoWuXi that was launched in October for customers to access WuXi oncology tumor models and capabilities more quickly and easily for cancer drug discovery and translational research.

18 Nov 2015

Study may lead to development of highly accurate screening test for early-stage ovarian cancer

Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.

17 Nov 2015

AstraZeneca announces FDA approval of TAGRISSO (AZD9291) for treatment of lung cancer patients

AstraZeneca today announced that the US Food and Drug Administration has approved TAGRISSO (AZD9291) 80mg once-daily tablets for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, who have progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy.

17 Nov 2015

Archbishop of York agrees to become Antibiotic Research UK's Patron

Antibiotic Research UK, a charity founded in 2014 to save modern medicine from the onslaught of superbugs, is delighted to announce that the Most Reverend & Right Honourable Dr John Sentamu, Archbishop of York has agreed to become the Charity’s Patron.

17 Nov 2015

IASLC commends FDA's decision to grant accelerated approval for new lung cancer therapy

The International Association for the Study of Lung Cancer commends the U.S. Food and Drug Administration's (FDA) decision to grant accelerated approval for osimertinib (Tagrisso), an oral medication for advanced non-small cell lung cancer (NSCLC) patients with a specific epidermal growth factor receptor (EGFR) mutation (T790M) and following progression after previous EGFR inhibitor therapies.

17 Nov 2015

New cancer control interventions may decrease cancer burden in low- and middle-income countries

In low-income and middle-income countries (LMICs), where 5.5 million of the world’s 8 million cancer deaths occur each year, most people with cancer have little or no access to treatment and many die in severe pain for lack of inexpensive opioid pain medicine.

17 Nov 2015

Researchers find greater genetic diversity among cancer cells than anticipated

The most rigorous genetic sequencing ever carried out on a single tumor reveals far greater genetic diversity among cancer cells than anticipated. Researchers from the University of Chicago and the Beijing Institute of Genomics estimate that the tumor, about 3.5 centimeters in diameter, contained more than 100 million distinct mutations within the coding regions of its genes—thousands of times more than expected.

10 Nov 2015

New funding for Centenary's life saving research

The Centenary Institute has welcomed the Federal Government’s announcement of funding for 9 new and innovative medical research projects via the latest round of NHMRC grant rounds funding, officially confirmed today.

9 Nov 2015

HIFU Prostate Services announces groundbreaking partnerships to offer prostate cancer treatments

HIFU Prostate Services, LLC, a leading provider of minimally-invasive prostate cancer treatment using High Intensity Focused Ultrasound ("HIFU"), announces groundbreaking partnerships with Michael J. Lazar, MD in Santa Rosa, Calif. and John H. Jurige, MD in Louisville, Ky., to offer HIFU treatments for prostate cancer.

9 Nov 2015

UM SOM Dean E. Albert Reece to be honored with 2015 David E. Rogers Award

The Association of American Medical Colleges announced today that University of Maryland School of Medicine Dean E. Albert Reece, MD, PhD, MBA, will receive the 2015 David E. Rogers Award, which honors a medical school faculty member who has made major contributions to improving the health and health care of the American people. He will be presented the Award on November 8, 2015 at the AAMC's Annual Awards Event.

6 Nov 2015

CK5 protein marks ovarian cancer likely to be resistant to cisplatin

A University of Colorado Cancer Center study recently published in the International Journal of Gynecological Cancer shows that protein cytokeratin 5 (CK5), known to be a marker of poor prognosis in breast cancer, also marks ovarian cancers likely to be resistant to the common chemotherapy cisplatin.

5 Nov 2015

New network formed to provide area-wide care for lung cancer patients in Northern Germany

The Pius Hospital Oldenburg, the Institute of Haematopathology Hamburg and NEO New Oncology AG announced today the formation of NOWEL, the North-East-West Lung Network.

4 Nov 2015

CA 19-9 tumor marker test can help predict early-stage pancreatic cancer patients

Only 1 in 5 U.S. pancreatic cancer patients receive a widely available, inexpensive blood test at diagnosis that can help predict whether they are likely to have a better or worse outcome than average and guide treatment accordingly, a Mayo Clinic study shows.

4 Nov 2015

Study explores benefits of breast cancer adjuvant therapies

After breast cancer surgery, women are prescribed adjuvant (or follow-up) therapies such as chemotherapy and endocrine drugs to reduce the risk of the cancer returning. It's been assumed that the treatment effects of these therapies remain constant over time, but a new study from the Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio suggests the opposite is true.

4 Nov 2015

Chemotherapy treatment can contribute to long-term neurocognitive deficits in pediatric brain tumor survivors

More children are surviving malignant brain tumors than in the past, thanks to the use of intense treatments using platinum-based chemotherapy (cisplatin and high-dose carboplatin). Unfortunately, the therapy has a known side effect of permanent hearing loss, resulting from damage to the inner ear.

4 Nov 2015

Innovative immunotherapy clinical trial underway at The University of Kansas Cancer Center

A novel immunotherapy clinical trial underway now at The University of Kansas Cancer Center has enrolled the first patients in the world to receive what many doctors and researchers believe is the future of cancer treatment.

4 Nov 2015

Duke University mathematicians developing ways to help doctors predict tumor growth

Mathematicians at Duke University are developing ways to help doctors predict how different cancers are likely to progress when actual measurements of tumor growth are hard to come by.

3 Nov 2015

UCLA study finds cost variation across entire care process for low-risk prostate cancer

Now, for the first time, UCLA researchers have described cost across an entire care process for low-risk prostate cancer - from the time a patient checks in for his first appointment to his post-treatment follow-up testing - using time-driven activity-based costing. And they found a wide variation in costs for the various available treatments that remained consistent over a 12-year period, indicating a better method to monitor costs could save valuable healthcare dollars, said study first author Dr. Aaron Laviana, a fifth year urology resident.

3 Nov 2015

Cancer DNA in patient's bloodstream could help deliver personalized treatment for liver cancer

Fragments of cancer DNA circulating in a patient's bloodstream could help doctors deliver more personalized treatment for liver cancer, Japanese researchers report.

2 Nov 2015

Cancer Therapy News and Research

VA announces new ROPA program to improve radiation therapy cancer care for Veterans

Med Data Quest collaborates with WuXi AppTec to tackle oncology informatics challenges

Study may lead to development of highly accurate screening test for early-stage ovarian cancer

AstraZeneca announces FDA approval of TAGRISSO (AZD9291) for treatment of lung cancer patients

Archbishop of York agrees to become Antibiotic Research UK's Patron

IASLC commends FDA's decision to grant accelerated approval for new lung cancer therapy

New cancer control interventions may decrease cancer burden in low- and middle-income countries

Researchers find greater genetic diversity among cancer cells than anticipated

New funding for Centenary's life saving research

HIFU Prostate Services announces groundbreaking partnerships to offer prostate cancer treatments

UM SOM Dean E. Albert Reece to be honored with 2015 David E. Rogers Award

CK5 protein marks ovarian cancer likely to be resistant to cisplatin

New network formed to provide area-wide care for lung cancer patients in Northern Germany

CA 19-9 tumor marker test can help predict early-stage pancreatic cancer patients

Study explores benefits of breast cancer adjuvant therapies

Chemotherapy treatment can contribute to long-term neurocognitive deficits in pediatric brain tumor survivors

Innovative immunotherapy clinical trial underway at The University of Kansas Cancer Center

Duke University mathematicians developing ways to help doctors predict tumor growth

UCLA study finds cost variation across entire care process for low-risk prostate cancer

Cancer DNA in patient's bloodstream could help deliver personalized treatment for liver cancer

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News